Blood-cancer medicine, manufactured in the US, won conditional approval for sale in mainland China last month.
Hutchmed weighs cancer drug’s supply-chain options amid US-China trade war
RELATED ARTICLES
Hong Kong man arrested for allegedly driving school bus under influence of drugs
Tower of peace or sin? Why China demands that a Japanese wartime monument be demolished
AMD chief Lisa Su visits Lenovo in Beijing as US hints at easing chip curbs
